# Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

> **NCT00157118** · PHASE2,PHASE3 · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 18 (actual)

## Conditions studied

- Protein C Deficiency

## Interventions

- **DRUG:** Protein C Concentrate (Human) Vapor Heated

## Key facts

- **NCT ID:** NCT00157118
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08-22
- **Primary completion:** 2005-03-17
- **Final completion:** 2005-03-17
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157118, "Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00157118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*